Never doubt if a small group of thoughtful, concerned scientists change the world. Indeed it is the only thing that ever has.
Keynote Speaker
We recognize that the quality of the speakers has a significant impact on audience engagement, which is why our in-house research team, with their years of experience in the industry, strives to bring only the best speakers with exciting topics to ensure that you are fully intact for the entire two days at the 13th CTSS.
Here’s a list of all the speakers, and the topics they’ll be talking about at the 13th CTSS.
STEPHEN LUTSCH
Director, Revolutionize Clinical Trials
Leo Pharma
ALEXANDER DEBTS
Lead Clinical Supply Innovation
MSD
ALINA PSZCZOLKOWSKA
Executive Director Study Management
AstraZeneca
WOLFGANG SCHLEIFER
Head Digital Delivery for Novartis Global Drug Development
Novartis
DR. DOMENICO MERANTE
VP Clinical Research Lead TA Orphan-Nephrology
CLS Vifor
DAVID GILLEN
Chief Medical Officer
Norgine
Sign up here to get a list of all the speakers, and the topics they’ll be talking about at the 13th CTSS.
Interested in a Speaking Slot?
Join the 13th CTSS and share your thoughts with the ones who are willing to stretch their limits.
A fantastic meeting and a fantastic day for everyone. I expect that the agenda's focus on enjoying the learning will include a wide range of topics, including patient engagement, modern centralization trials, and many more. Thank you for inviting me to participate in this summit.
Craig LipsetAdvisor and Founder at Clinical Innovation Partners 
I could like to thank the opportunity to participate as a speaker of the CTSS Series organized by AFSG. This has been a unique experience to interact with the inperson space. We restructured clinical research specialists to learn from one another and establish a global community ready to collaborate and confront the forthcoming difficulties of clinical trials as a single unit. I am anxious to be part of the next summits in 2023. Hopefully, we'll see each other again.
Guillermo CalettiHead of Clinical Operations, Boehringer Ingelheim 
It's been interesting to hear different types of presentations, such as the one I gave earlier when I was speaking and taking notes. I enjoy hearing a variety of perspectives from the many speakers. Because it provides information from me as well as validation of what I don't know.
Linda PetersonVice President Clinical Operations at Global Regulatory Writing & Consulting, Inc. 
Thank you for including TTC Oncology in Clinical Trials Strategic Summit, it had a very interesting spread of different topics and I would like to see similar variety in future conferences.
Arkadiusz DudekCMO, TTC Oncology 
Previous
Next
A fantastic meeting and a fantastic day for everyone. I expect that the agenda's focus on enjoying the learning will include a wide range of topics, including patient engagement, modern centralization trials, and many more. Thank you for inviting me to participate in this summit.
Craig LipsetAdvisor and Founder at Clinical Innovation Partners
I could like to thank the opportunity to participate as a speaker of the CTSS Series organized by AFSG. This has been a unique experience to interact with the inperson space. We restructured clinical research specialists to learn from one another and establish a global community ready to collaborate and confront the forthcoming difficulties of clinical trials as a single unit. I am anxious to be part of the next summits in 2023. Hopefully, we'll see each other again.
Guillermo CalettiHead of Clinical Operations, Boehringer Ingelheim
It's been interesting to hear different types of presentations, such as the one I gave earlier when I was speaking and taking notes. I enjoy hearing a variety of perspectives from the many speakers. Because it provides information from me as well as validation of what I don't know.
Linda PetersonVice President Clinical Operations at Global Regulatory Writing & Consulting, Inc.
Thank you for including TTC Oncology in Clinical Trials Strategic Summit, it had a very interesting spread of different topics and I would like to see similar variety in future conferences.
Arkadiusz DudekCMO, TTC Oncology
Previous
Next
